Impact of age on treatment and outcomes in ST-elevation myocardial infarction

American Heart Journal

Volumn 161, Issue 4, 2011, Pages 664-672

  Newell, Marc C ^a   Henry, Jason T ^a   Henry, Timothy D ^a,b   Duval, Sue ^a,b   Browning, Joseph A ^a,b   Christiansen, Ellen C ^a   Larson, David M ^a,c   Berger, Alan K ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Ridgeview Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; AGE; COMPARATIVE STUDY; HEART INFARCTION; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958722071     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.12.018     Document Type: Article

References (40)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003;163:2345-53. (Pubitemid 37310196)
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Investigators. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12, 490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
4. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417-22.
5. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
6. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41, 299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
7. Krumholz HM, Gross CP, Peterson ED, et al. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-I Study. Am Heart J 2003;146:839-47. (Pubitemid 37378573)
8. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-e292.
9. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8. (Pubitemid 28016233)
10. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
11. Dalby M, Bouzamondo A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003;108:1809-14. (Pubitemid 37296089)
12. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42. (Pubitemid 37010777)
13. Widimský P, Budesínský T, Vorác D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104. (Pubitemid 36109551)
14. Widimský P, Groch L, Zelízko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-31. (Pubitemid 30240769)
15. Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007;116:721-8. (Pubitemid 47255989)
16. de Boer MJ, Ottervanger JP, van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002;39:1723-8.
17. Grines CL, SENIOR-PAMI. A prospective randomized trial of primary angioplasty and thrombolytic therapy in elderly patients with acute myocardial infarction. Transcatheter Cardiovascular Therapeutics (TCT) Conference 2005. Washington, DC; 2005.
18. Goldenberg I, Matetzky S, Halkin A, et al. Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2003;145:862-7. (Pubitemid 36570957)
19. Mehta RH, Sadiq I, Goldberg RJ, et al. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J 2004;147:253-9. (Pubitemid 38176825)
20. Berger AK, Schulman KA, Gersh BJ, et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999;282:341-8. (Pubitemid 29350488)
21. Zeymer U, Gitt A, Winkler R, et al. Mortality of patients who are older than 75 years after ST elevation myocardial infarction in clinical practice. Dtsch Med Wochenschr 2005;130:633-6. (Pubitemid 40515466)
22. National Registry of Myocardial Infarction Web site. Available at: http://www.nrmi.org. Last accessed April 4, 2007.
23. Henry TD, Unger BT, Sharkey SW, et al. Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention. Am Heart J 2005;150:373-84. (Pubitemid 41317599)
24. Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 2007;115:2570-89. (Pubitemid 46766537)
25. Berger AK, Radford MJ, Wang Y, et al. Thrombolytic therapy in older patients. J Am Coll Cardiol 2000;36:366-74. (Pubitemid 30627411)
26. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med 1996;124:292-8. (Pubitemid 26047454)
27. Krumholz HM, Radford MJ, Wang Y, et al. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 1999;131:648-54. (Pubitemid 29517949)
28. Krumholz HM, Vaccarino V, Ellerbeck EF, et al. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons =65 years of age. Am J Cardiol 1997;79:581-6.
29. Berger AK, Duval SJ, Armstrong C, et al. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study. Am J Geriatr Cardiol 2007;16:15-23.
30. Gränsbo K, Melander O, Wallentin L, et al. Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol 2010;55:1362-9.
31. Sinnaeve PR, Huang Y, Bogaerts K, et al. Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. Am Heart J 2006;152:684 e1-9.
32. Antoniucci D, Valenti R, Santoro GM, et al. Systematic primary angioplasty in octogenarian and older patients. Am Heart J 1999;138:670-4. (Pubitemid 29471041)
33. Yip HK, Wu CJ, Chang HW, et al. Comparison of primary angioplasty and conservative treatment on short-and long-term outcome in octogenarian or older patients with acute myocardial infarction. Jpn Heart J 2002;43:463-74.
34. Gottlieb S, Behar S, Hod H, et al. Trends in management, hospital and long-term outcomes of elderly patients with acute myocardial infarction. Am J Med 2007;120:90-7. (Pubitemid 46039802)
35. Alexander KP, Roe MT, Chen AY, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE national quality improvement initiative. J Am Coll Cardiol 2005;46:1479-87. (Pubitemid 41446182)
36. Boucher JM, Racine N, Thanh TH, et al. Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ 2001;164:1285-90. (Pubitemid 32702038)
37. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7. (Pubitemid 34158943)
38. Krumholz HM, Murillo JE, Chen J, et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997;277:1683-8. (Pubitemid 27232742)
39. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndrome. Am Heart J 2001;141:190-9.
40. Kushner FG, Hand M, Antman EM, et al. Focused updates: ACC/AHA guidelines for the management of patients with STelevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). J Am Coll Cardiol 2009;54:2205-41.